KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rentokil Initial (RTO) Return on Sales (2022 - 2024)

Historic Return on Sales for Rentokil Initial (RTO) over the last 3 years, with Q2 2024 value amounting to 1.73%.

  • Rentokil Initial's Return on Sales fell 1400.0% to 1.73% in Q2 2024 from the same period last year, while for Jun 2024 it was 1.73%, marking a year-over-year decrease of 1400.0%. This contributed to the annual value of 0.06% for FY2024, which is 100.0% down from last year.
  • As of Q2 2024, Rentokil Initial's Return on Sales stood at 1.73%, which was down 1400.0% from 1.1% recorded in Q4 2023.
  • Rentokil Initial's Return on Sales' 5-year high stood at 0.12% during Q4 2022, with a 5-year trough of 1.73% in Q2 2024.
  • Moreover, its 3-year median value for Return on Sales was 1.35% (2023), whereas its average is 1.08%.
  • Its Return on Sales has fluctuated over the past 5 years, first crashed by -12200bps in 2023, then tumbled by -1400bps in 2024.
  • Over the past 3 years, Rentokil Initial's Return on Sales (Quarter) stood at 0.12% in 2022, then plummeted by -1018bps to 1.1% in 2023, then crashed by -57bps to 1.73% in 2024.
  • Its Return on Sales stands at 1.73% for Q2 2024, versus 1.1% for Q4 2023 and 1.6% for Q2 2023.